Modified
nucleoside triphosphates (NTPs) are powerful probes and
medicines, but their anionic character impedes membrane permeability.
As such, invasive delivery techniques, transport carriers, or prodrug
strategies are required for their in vivo use. Here,
we present a fluorescent 2′-deoxyribonucleoside triphosphate
“TAMRA-dATP” that exhibits surprisingly high bioavailability in vivo. TAMRA-dATP spontaneously forms nanoparticles in
Mg+2-containing buffers that are taken into the vesicles
of living cells and animals by energy-dependent processes. In cell
cultures, photochemical activation with yellow laser light (561 nm)
facilitated endosomal escape of TAMRA-dATP, resulting in its metabolic
incorporation into DNA in vitro. In contrast, in vivo studies revealed that TAMRA-dATP is extensively
trafficked by active pathways into cellular DNA of zebrafish (Danio rerio) and Caenorhabditis elegans where DNA labeling was observed in live animals, even without photochemical
release. Metabolic labeling of DNA in whole, living animals can therefore
be achieved by simply soaking animals in a buffer containing TAMRA-dATP
or a structurally related compound, Cy3-dATP.